1. Home
  2. PLUT vs RADX Comparison

PLUT vs RADX Comparison

Compare PLUT & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUT
  • RADX
  • Stock Information
  • Founded
  • PLUT 2018
  • RADX 2021
  • Country
  • PLUT Hong Kong
  • RADX Australia
  • Employees
  • PLUT N/A
  • RADX N/A
  • Industry
  • PLUT
  • RADX
  • Sector
  • PLUT
  • RADX
  • Exchange
  • PLUT NYSE
  • RADX NYSE
  • Market Cap
  • PLUT 42.9M
  • RADX 38.4M
  • IPO Year
  • PLUT 2025
  • RADX N/A
  • Fundamental
  • Price
  • PLUT $2.55
  • RADX $5.40
  • Analyst Decision
  • PLUT
  • RADX Strong Buy
  • Analyst Count
  • PLUT 0
  • RADX 1
  • Target Price
  • PLUT N/A
  • RADX $15.00
  • AVG Volume (30 Days)
  • PLUT 104.0K
  • RADX 508.2K
  • Earning Date
  • PLUT 01-01-0001
  • RADX 02-26-2025
  • Dividend Yield
  • PLUT N/A
  • RADX N/A
  • EPS Growth
  • PLUT N/A
  • RADX N/A
  • EPS
  • PLUT N/A
  • RADX N/A
  • Revenue
  • PLUT $952,965.00
  • RADX $204,609.00
  • Revenue This Year
  • PLUT N/A
  • RADX N/A
  • Revenue Next Year
  • PLUT N/A
  • RADX N/A
  • P/E Ratio
  • PLUT N/A
  • RADX N/A
  • Revenue Growth
  • PLUT N/A
  • RADX N/A
  • 52 Week Low
  • PLUT $2.26
  • RADX $3.55
  • 52 Week High
  • PLUT $4.22
  • RADX $50.82
  • Technical
  • Relative Strength Index (RSI)
  • PLUT N/A
  • RADX N/A
  • Support Level
  • PLUT N/A
  • RADX N/A
  • Resistance Level
  • PLUT N/A
  • RADX N/A
  • Average True Range (ATR)
  • PLUT 0.00
  • RADX 0.00
  • MACD
  • PLUT 0.00
  • RADX 0.00
  • Stochastic Oscillator
  • PLUT 0.00
  • RADX 0.00

About PLUT PLUTUS FINANCIAL GROUP LIMITED

Plutus Financial Group Ltd provides financial services. It mainly offers (i) securities dealings and brokerage services (ii) margin financing services and (iii) underwriting and placing services.

About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD

Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.

Share on Social Networks: